Genomic Health, Inc
|
(Name of Issuer)
|
Common Stock, par value $0.0001 per share
|
(Title of Class of Securities)
|
37244C101
|
||
(CUSIP Number)
|
Leo Kirby
667 Madison Avenue, 21st Floor
New York, NY 10065
(212) 339-5633
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
November 11, 2011
|
||
(Date of Event which Requires Filing of this Statement)
|
CUSIP No. 37244C101
|
Page 2 of 8 Pages
|
1
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Julian C. Baker
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) ¨
|
(b) ¨
|
||
3
|
SEC USE ONLY
|
|
4
|
SOURCE OF FUNDS (See Instructions)
WC
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
41,250
|
8
|
SHARED VOTING POWER
8,583,341
|
|
9
|
SOLE DISPOSITIVE POWER
41,250
|
|
10
|
SHARED DISPOSITIVE POWER
8,583,341
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,624,591
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
29.2%
|
|
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
CUSIP No. 37244C101
|
Page 3 of 8 Pages
|
1
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Felix J. Baker
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) ¨
|
(b) ¨
|
||
3
|
SEC USE ONLY
|
|
4
|
SOURCE OF FUNDS (See Instructions)
WC
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
8,583,341
|
|
9
|
SOLE DISPOSITIVE POWER
0
|
|
10
|
SHARED DISPOSITIVE POWER
8,583,341
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,583,341
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
29.0%
|
|
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
Item 5.
|
Interest in Securities of the Issuer.
|
Name
|
Number of
Shares
|
Percent of Class
Outstanding
|
||||||
Baker Bros. Investments, L.P.
|
173,897 | 0.6 | % | |||||
Baker Bros. Investments II, L.P.
|
13,238 | 0.0 | % | |||||
667, L.P.
|
1,254,773 | 4.3 | % | |||||
Baker Brothers Life Sciences, L.P.
|
6,590,213 | 22.3 | % | |||||
14159, L.P.
|
183,162 | 0.6 | % | |||||
FBB Associates
|
173,897 | 0.6 | % | |||||
Baker/Tisch Investments, L.P.
|
194,161 | 0.7 | % | |||||
Julian C. Baker
|
41,250 | 0.1 | % | |||||
Total
|
8,624,591 | 29.2 | % |
Name
|
Date
|
Number of
Shares
|
Transaction
|
Price/ Share
|
||||||
667, L.P.
|
11/3/2011
|
5 |
Purchase
|
24.419 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/3/2011
|
954 |
Purchase
|
24.419 | ||||||
14159, L.P.
|
11/3/2011
|
41 |
Purchase
|
24.419 | ||||||
667, L.P.
|
11/3/2011
|
115 |
Purchase
|
24.486 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/3/2011
|
20267 |
Purchase
|
24.486 | ||||||
14159, L.P.
|
11/3/2011
|
857 |
Purchase
|
24.486 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/4/2011
|
55,920 |
Purchase
|
25.7772 | ||||||
14159, L.P.
|
11/4/2011
|
2,365 |
Purchase
|
25.7772 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/7/2011
|
72,209 |
Purchase
|
26.2793 | ||||||
14159, L.P.
|
11/7/2011
|
3,046 |
Purchase
|
26.2793 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/7/2011
|
60,162 |
Purchase
|
26.2031 | ||||||
14159, L.P.
|
11/7/2011
|
2,538 |
Purchase
|
26.2031 | ||||||
667, L.P.
|
11/9/2011
|
484 |
Purchase
|
26.8042 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/9/2011
|
64,754 |
Purchase
|
26.8042 | ||||||
14159, L.P.
|
11/9/2011
|
2,661 |
Purchase
|
26.8042 | ||||||
667, L.P.
|
11/9/2011
|
58 |
Purchase
|
26.6634 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/9/2011
|
7,725 |
Purchase
|
26.6634 | ||||||
14159, L.P.
|
11/9/2011
|
317 |
Purchase
|
26.6634 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/10/2011
|
36,956 |
Purchase
|
26.8875 | ||||||
14159, L.P.
|
11/10/2011
|
1,509 |
Purchase
|
26.8875 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/11/2011
|
100,823 |
Purchase
|
27.6624 | ||||||
14159, L.P.
|
11/11/2011
|
4,052 |
Purchase
|
27.6624 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/14/2011
|
39,117 |
Purchase
|
27.2539 | ||||||
14159, L.P.
|
11/14/2011
|
1,567 |
Purchase
|
27.2539 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/15/2011
|
16,583 |
Purchase
|
27.9859 | ||||||
14159, L.P.
|
11/15/2011
|
657 |
Purchase
|
27.9859 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/15/2011
|
23,758 |
Purchase
|
27.8971 | ||||||
14159, L.P.
|
11/15/2011
|
942 |
Purchase
|
27.8971 | ||||||
667, L.P.
|
11/16/2011
|
273 |
Purchase
|
27.2426 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/16/2011
|
14,482 |
Purchase
|
27.2426 | ||||||
14159, L.P.
|
11/16/2011
|
568 |
Purchase
|
27.2426 | ||||||
667, L.P.
|
11/16/2011
|
185 |
Purchase
|
27.4998 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/16/2011
|
9,774 |
Purchase
|
27.4998 | ||||||
14159, L.P.
|
11/16/2011
|
383 |
Purchase
|
27.4998 |
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
Item 7.
|
Material to Be Filed as Exhibits.
|
Exhibit 1.
|
Agreement regarding the joint filing of this statement.
|
By:
|
/s/ Julian C. Baker
|
|
Julian C. Baker
|
||
By:
|
/s/ Felix J. Baker
|
|
Felix J. Baker
|
By:
|
/s/ Julian C. Baker
|
|
Julian C. Baker
|
||
By:
|
/s/ Felix J. Baker
|
|
Felix J. Baker
|